DR. BHUDEV SHARMA, M.D.
Osteopathic Medicine at James St, Edison, NJ
License number
New Jersey MA32153
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
98 James St SUITE 300, Edison, NJ 08820
622 Georges Rd STE 303, New Brunswick, NJ 08902
622 Georges Rd STE 303, New Brunswick, NJ 08902
Phone
(732) 548-2523
(732) 549-8827 (Fax)
(732) 745-4994
(732) 745-7044 (Fax)
(732) 549-8827 (Fax)
(732) 745-4994
(732) 745-7044 (Fax)
Personal information
See more information about BHUDEV SHARMA at radaris.comName
Address
Phone
98 James St, Edison, NJ 08820
96 Main St, Milltown, NJ 08850
95 Main St, Milltown, NJ 08850
95 Main St, Milltown, NJ 08850
622 Georges Rd, North Brunswick, NJ 08902
Organization information
See more information about BHUDEV SHARMA at bizstanding.comBhudev Sharma MD
98 James St, Edison, NJ 08820
Categories:
Physicians & Surgeons Information & Referral Services
Phone:
(732) 549-8827 (Phone)
Products:
Referrals
Bhudev Sharma MD,MBBS,BS
622 Georges Rd, North Brunswick, NJ 08902
Industry:
Cardiologist, Internist
Phone:
(732) 828-0444 (Phone)
Bhudev M. Sharma
BHUDEV SHARMA, M.D.P.A
Edison, NJ
Registration:
Mar 20, 1996
State ID:
0100659175
Business type:
PA
Professional information
Dr. Bhudev Sharma, Edison NJ - MD (Doctor of Medicine)
Specialties:
Cardiology, Internal Medicine
Address:
Prime Care Medical Group PA
98 James St SUITE 300, Edison 08820
(732) 548-2523 (Phone)
Prime Care Medical Group
622 Georges Rd SUITE 303, North Brunswick 08902
(732) 828-0444 (Phone)
98 James St SUITE 300, Edison 08820
(732) 548-2523 (Phone)
Prime Care Medical Group
622 Georges Rd SUITE 303, North Brunswick 08902
(732) 828-0444 (Phone)
Procedures:
Cardiac Echocardiography (ECG), Cardiac Nuclear Stress Test, Cardiac Stress Echocardiography (ECG), Cardioversion, Echocardiogram, EKG (Electrocardiogram, ECG), Radiofrequency Ablation
Conditions:
Atrial Fibrillation, Cardiac Arrest, Cardiac Arrhythmia, Cardiomyopathy, Cardiovascular Diseases, Congestive Heart Failure, Coronary Artery Disease (CAD), Heart Attack (Acute Myocardial Infarction), Heart Disease, Heart Palpitations, High Blood Pressure, High Cholesterol, Hypertension, Syncope
Certifications:
Cardiology, Cardiovascular Disease, 2000, Internal Medicine
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Prime Care Medical Group PA
98 James St SUITE 300, Edison 08820
Prime Care Medical Group
622 Georges Rd SUITE 303, North Brunswick 08902
Robert Wood Johnson University Hospital
1 Robert Wood Johnson Pl, New Brunswick 08903
Saint Peter's University Hospital
254 Easton Ave, New Brunswick 08901
JFK Medical Center
65 James St, Edison 08818
98 James St SUITE 300, Edison 08820
Prime Care Medical Group
622 Georges Rd SUITE 303, North Brunswick 08902
Robert Wood Johnson University Hospital
1 Robert Wood Johnson Pl, New Brunswick 08903
Saint Peter's University Hospital
254 Easton Ave, New Brunswick 08901
JFK Medical Center
65 James St, Edison 08818
Education:
Medical School
University College Of Medical Sciences, Delhi University
Graduated: 1975
Martland Cmdnj
Graduated: 1976
Graduated: 1978
Graduated: 1980
University College Of Medical Sciences, Delhi University
Graduated: 1975
Martland Cmdnj
Graduated: 1976
Graduated: 1978
Graduated: 1980
Formulations And Use Of A Beta-Blocker And An Ace-Inhibitor For The Treatment Of Cardiovascular Diseases
US Patent:
2005003, Feb 10, 2005
Filed:
Aug 7, 2003
Appl. No.:
10/635443
Inventors:
Temple Okarter - Montvale NJ, US
Richard Aiena - Howell NJ, US
Bhudev Sharma - Edison NJ, US
Richard Aiena - Howell NJ, US
Bhudev Sharma - Edison NJ, US
International Classification:
A61K031/401, A61K031/137
US Classification:
514423000, 514651000
Abstract:
The use of a beta-blocker and an ACE-inhibitor in combination for the treatment of cardiovascular disorders, including hypertension and congestive heart failure, is provided. In particular, pharmaceutical formulations which use metoprolol tartrate and enalapril maleate in a therapeutically effective combination in a single extended release dosing unit for the treatment of congestive heart failure are disclosed as well as methods of using those formulations, thereby resulting in a decrease in a patient's overall pill burden.